# Characteristics and Impacts of X-linked Hypohidrotic Ectodermal Dysplasia (XLHED) in Boys: An Observational International Study

> **NCT07096206** · — · ACTIVE_NOT_RECRUITING · sponsor: **Pierre Fabre Medicament** · enrollment: 27 (actual)

## Conditions studied

- X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07096206
- **Lead sponsor:** Pierre Fabre Medicament
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-07-19
- **Primary completion:** 2026-11-19
- **Final completion:** 2026-11-19
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2025-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07096206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07096206, "Characteristics and Impacts of X-linked Hypohidrotic Ectodermal Dysplasia (XLHED) in Boys: An Observational International Study". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07096206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*